U.K. Policy Researchers Fear Ministry Censors

London - A new government policy has brought into sharp focus a simmering row between British academics and the Department of Health and Social Security on the integrity of their research findings. The immediate problem stems from new contract language specifying that publication of findings "is subject to the proper consent of the secretary of state, which consent shall not be unreasonably withheld." Under the terms of the old contract, which covers social policy research commissioned by the

Written byMelanie Phillips
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The immediate problem stems from new contract language specifying that publication of findings "is subject to the proper consent of the secretary of state, which consent shall not be unreasonably withheld." Under the terms of the old contract, which covers social policy research commissioned by the DHSS, department officials had a period of time to comment upon the findings but were unable to alter the findings or block publication. Not surprisingly, researchers feel that the new terms invite political censorship, and they are unwilling to believe assurances given to them by the DHSS that this will not occur. Many heads of research units icy has brought into sharp focus a are accordingly refusing to sign the new contract.

Last month Health Minister Tony Newton appeared before a committee of the House of Lords to try to allay such fears. He told them that the change was done purely 'for legal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA